UCSF The Medical Management of AIDS and Key Infections 2025

Description

+ Include: 39 videos + 39 file sub vtt + 27 pdfs, size: 9.44 GB

+ Target Audience: intermediate-to-advanced HIV clinicians, infectious disease specialists

+ Sample video: contact me for sample video

+ Information:

UCSF The Medical Management of AIDS and Key Infections
In-Person and Virtual Options available: December 11 – 12, 2025
**Fully Virtual on December 13, 2025 for all attendees**

Overview

This course provides the active, intermediate-to-advanced clinician with a comprehensive review of the science of HIV and key infections including HCV, HBV, RSV, H5N1 and COVID, as well as an update on the application of appropriate therapies. Safe and effective use of antiretroviral therapy for both prevention of HIV and treatment of HIV is an indispensable foundational skill which this course emphasizes. Available and emerging ART strategies will be reviewed in depth, including new long-acting injectables and oral formulations. Providing successful care for people living with HIV/AIDS in 2025 also involves understanding and treating myriad co-morbid conditions in the fields of cardiology, gastroenterology, endocrinology, dermatology, neurology, behavioral medicine, and addiction medicine. Close collaboration with other specialists and diverse teams of health professionals is vital for the best care of our complex patients. All course lecturers are leading clinicians and/or researchers who are dedicated to teaching in their areas of expertise. All course lecturers are leading clinicians and/or researchers who are dedicated to teaching in their areas of expertise.

For ambitious new clinicians who want a challenge, we still offer our New Clinicians Track (NCT). This track provides five additional lectures that cover antiretroviral therapy (ART) 101, basic HIV pharmacology, management of ART resistance, IRIS, and opportunistic infections.

Objectives

An attendee completing this course will be able to improve skills and strategies to:

• Diagnose, treat, and prevent important conditions in HIV medicine and HIV medicine subspecialties, for improved patient outcomes;
• Apply in practice the latest treatment guidelines and recommendations for the prevention of HIV transmission and the appropriate use of PEP, PrEP and DoxyPEP including the use of long-acting options;
• Apply new recommendations for initiating and timely switching of antiretroviral combinations including long-acting ART in appropriate patients;
• Identify new developments and apply treatment recommendations in HIV related, dermatologic, metabolic, cardiovascular, and addiction medicine;
• Diagnose and apply new recommendations for the treatment of HBV, HCV, cirrhosis, MASH and MASLD;
• Align practice patterns more with current evidence and guidelines for treating STI’s and HIV;
• Apply in practice the latest transmission prevention guidelines for COVID, Influenza, and RSV as well as the updated treatment guidelines for COVID, Influenza and RSV;
• Apply new recommendations for appropriate treatment of acute COVID-19 and Long COVID

 

+ Topics:

Thursday,  Dec 11, 2025		Robertson Auditorium, 2nd Floor
7:30AM		Breakfast and Registration Open
8:00AM		Introduction	Drs. Diane Havlir, Meg Newman, & Annie Luetkemeyer
		PLENARY SESSION I: State of HIV: 2025 Perspective
8:10		Top Ten Issues in HIV Medicine	Dr. Diane Havlir
8:50		HIV Cure: Hope & Hype	Dr. Steven Deeks
9:30		Opportunities and Challenges in STI Prevention and Treatment	Dr. Stephanie Cohen
10:10		Break
		PLENARY SESSION II: HIV Prevention
10:40		HIV Prevention: The Changing Landscape	Dr. Susan Buchbinder
11:15		Cases & Controversies in PEP, PrEP & STI prevention	Moderator: Dr. Oliver Bacon Panelists: Drs. Stephanie Cohen, Franco Chevalier, Hyman Scott
11:55		Prevention Panel: Q&A	Drs. Bacon, Chevalier, Cohen, Scott
12:10PM		Lunch on Own
		OPTIONAL LUNCH WORKSHOPS:
12:35-1:20		NCTNew Clinicians’ Workshop: ART101:   Antiretroviral Therapy Initiation: From Guidelines to Practice	Dr. Vivek Jain
12:35-1:20		Rapid Fire Derm for Primary Care	Drs. Herbert Castillo Villardares and Sarah Coates
		PLENARY SESSION IlI: Antiretroviral Therapy – State of the ART
1:30		Introductory Remarks	Dr. Mark Smith
1:40		Long-acting Formulations: HIV and Beyond	Dr. Charles Flexner
2:20		The State of the Art of ART	Dr. Monica Gandhi
3:00		Break
3:30		Cases & Challenges with ART	Moderator: Dr. Anne Fenton Panelists: Drs. Gabe Chamie, Carina Marquez, Jorge Salazar
		PLENARY SESSION IV: Complications of HIV
4:10		Great Cases from the Bay	Moderator: Dr. Andrew Kerkhoff Panelists: Drs. Jawara Allen, Grace Haser, Sophie Lewis
4:45		Challenging HIV Neurology Cases	Dr. Felicia Chow and Dr. Paul Pritikanta
5:20PM		Adjourn
Friday,  Dec 12, 2025
7:30AM		Breakfast and Registration Open
		Plenary Session V:  New strategies for Preventing and Managing Infections in 2025: Vaccines, RSV, COVID & More
8:00AM	G	RSV, Flu and more: Latest Updates in Respiratory Infections	Dr. Carina Marquez Dr. Ted Ruel
8:35	G	Practical Approaches to Diagnosing, Treating & Preventing Long COVID	Dr. Michael Peluso
9:05	G	Innovative Strategies for Bacterial Infections: Making Dalbavancin Work for our Patients	Dr. Vivek Jain
9:30	G	Rapid Fire Vaccines questions and answers	Drs. Jain, Peluso, Marquez, Ruel
10:10		Break
		PLENARY SESSION VI: WEIGHT MANAGEMENT &  ENDOCRINOLOGY
10:40	G	Weight Management: Cases from the Clinic	Dr. Matthew Hickey
11:10		Endocrine Updates for 2025	Dr. Lisa Murphy
11:45		Lunch on Own
		OPTIONAL LUNCH WORKSHOPS:
		TRACK A
12:30-1:20PM		A Panel on Emerging AI and Digital Tools for the Clinician Robertson Auditorium, 2nd Floor	Dr. Vivek Jain Dr. Xinran (Leo) Liu Dr. Brian Schwartz
		TRACK B
		NCTNew Clinicians’ Workshop
12:30-1:20		The Building Blocks of HIV Therapy Pub Lounge, 1st Floor	Dr. Parya Saberi
		PLENARY SESSION VII:  SEXUAL & REPRODUCTIVE HEALTH
1:30		Cases from the STI Clinic in 2025	Dr. Oliver Bacon
2:05		Reproductive & Gyn Care in HIV Medicine	Dr. Dominika Siedman and Dr. Lealah Pollock
		PLENARY SESSION VIII: DERMATOLOGY
2:40		HIV Dermatology: Cases from the Clinic	Dr. Kieron Leslie
3:20		Break
		PARALLEL TRACKS (choose one)
		NCTNew Clinicians’ Workshops
3:50-4:30		NCTIntroduction to ARV Drug Resistance Robertson Auditorium, 2nd Floor	Dr. Susa Coffey
4:35-5:15PM		NCT Cases from the Inpatient HIV Service: OI’s and IRIS Robertson Auditorium, 2nd Floor	Drs. Andrew Kerkhoff and Grace Haser
		Infectious Disease Updates for HIV Clinicians
3:50-4:30		What’s New in TB?	Dr. Gustavo Velasquez
4:35-5:15		Images in Clinical Medicine	Dr. Matt Spinelli
5:15		Adjourn
Saturday,  Dec 13, 2025		ZOOM ONLY
		PLENARY SESSION IX: Optimizing Care of the HIV Patient
8:00AM	G	What’s new in HCV	Dr. Annie Luetkemeyer
8:30	G	Updates from the Hepatitis Clinic: MASLD, MASH, and More!	Dr. Jenny Price
9:00	G	Challenging Hepatitis Cases from the Clinic	Dr. David Thomas
9:25	G	Liver Panel	Drs. Luetkemeyer, Price, Thomas
9:40		Break
10:10	P	Substance Use Trends in the US: What Providers Need to Know	Dr. Katherine Grieco
10:40	P	Cases in Addiction Medicine and Pain Management	Dr. Ayesha Appa
11:10	P	Practical Psychiatric Pearls	Dr. William Smith
11:40	P	Interactive Panel: Psychiatry & Managing Substance Use and Pain	Dr. Paula Lum and Drs. Appa, Grieco & Smith
12:00PM		Lunch on Own
		PLENARY SESSION X: ART Management Updates ZOOM ONLY
1:00		ART Panel: Integrating Your Knowledge: What Would You Recommend for These Patients?	Moderator: Dr. Susa Coffey Panelists: Drs. Brad Hare, Anne Fenton, Annie Luetkemeyer
1:50	G	ID Pearls for HIV Providers	Dr. Lisa Winston
2:25		Break
2:40	G	HIV Cardiology in 2025: What you Need to Know	Dr. Priscilla Hsue Dr. Matt Durstenfeld
3:20		Closing Remarks	Drs. Havlir, Newman, Luetkemeyer
3:30PM		Adjourn